Brief: Pulmatrix Announces Cross License Agreement And Transfer Of Laboratory To Mannkind Corporation
29/05/2024 13:57
May 29 (Reuters) - MannKind Corp MNKD.O :
* PULMATRIX ANNOUNCES CROSS LICENSE AGREEMENT AND TRANSFER
OF
LABORATORY TO MANNKIND CORPORATION
* PULMATRIX INC - ASSUMPTION OF OUR LEASE AND LABORATORY BY
MANNKIND HELPS EXTEND OUR CASH RUNWAY FURTHER INTO 2026
* PULMATRIX INC - AS PART OF TRANSACTION, MANNKIND WILL
ASSUME
LEASE OF BEDFORD, MASS., RESEARCH AND DEVELOPMENT FACILITY
Source text for Eikon: ID:nPn35mnLza
Further company coverage: MNKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children